Dr. Stephanie Venn-Watson is the CEO of Seraphina Therapeutics which has been recognized for its extensive research and education on pentadecanoic acid (C15:0). Show sponsor: Show notes:
Get AI-powered summaries and transcripts for any meeting, phone call, or podcast.
Available on iOS, Android, Mac, and Windows
Want AI summaries for your own recordings? Try Wave AI free →
No transcript available.
